307 related articles for article (PubMed ID: 20472252)
1. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome.
Seligman NS; Almario CV; Hayes EJ; Dysart KC; Berghella V; Baxter JK
J Pediatr; 2010 Sep; 157(3):428-33, 433.e1. PubMed ID: 20472252
[TBL] [Abstract][Full Text] [Related]
2. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
[TBL] [Abstract][Full Text] [Related]
3. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
[TBL] [Abstract][Full Text] [Related]
4. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.
Isemann B; Meinzen-Derr J; Akinbi H
J Perinatol; 2011 Jan; 31(1):25-9. PubMed ID: 20508596
[TBL] [Abstract][Full Text] [Related]
5. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis.
Cleary BJ; Donnelly J; Strawbridge J; Gallagher PJ; Fahey T; Clarke M; Murphy DJ
Addiction; 2010 Dec; 105(12):2071-84. PubMed ID: 20840198
[TBL] [Abstract][Full Text] [Related]
6. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes.
McCarthy JJ; Leamon MH; Parr MS; Anania B
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):606-10. PubMed ID: 16150249
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
8. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
[TBL] [Abstract][Full Text] [Related]
9. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
Dryden C; Young D; Hepburn M; Mactier H
BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
[TBL] [Abstract][Full Text] [Related]
10. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources.
Arlettaz R; Kashiwagi M; Das-Kundu S; Fauchère JC; Lang A; Bucher HU
Acta Obstet Gynecol Scand; 2005 Feb; 84(2):145-50. PubMed ID: 15683374
[TBL] [Abstract][Full Text] [Related]
11. Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome.
Dysart K; Hsieh HC; Kaltenbach K; Greenspan JS
J Perinat Med; 2007; 35(4):344-6. PubMed ID: 17511598
[TBL] [Abstract][Full Text] [Related]
12. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
13. Higher maternal doses of methadone does not increase neonatal abstinence syndrome.
Pizarro D; Habli M; Grier M; Bombrys A; Sibai B; Livingston J
J Subst Abuse Treat; 2011 Apr; 40(3):295-8. PubMed ID: 21255960
[TBL] [Abstract][Full Text] [Related]
14. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome.
Lim S; Prasad MR; Samuels P; Gardner DK; Cordero L
Am J Obstet Gynecol; 2009 Jan; 200(1):70.e1-5. PubMed ID: 18976737
[TBL] [Abstract][Full Text] [Related]
15. Gender and NAS: does sex matter?
Holbrook A; Kaltenbach K
Drug Alcohol Depend; 2010 Nov; 112(1-2):156-9. PubMed ID: 20576365
[TBL] [Abstract][Full Text] [Related]
16. The effect of methadone dose regimen on neonatal abstinence syndrome.
McCarthy JJ; Leamon MH; Willits NH; Salo R
J Addict Med; 2015; 9(2):105-10. PubMed ID: 25599433
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
[TBL] [Abstract][Full Text] [Related]
18. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.
Burns L; Mattick RP
Drug Alcohol Rev; 2007 Sep; 26(5):487-92. PubMed ID: 17701511
[TBL] [Abstract][Full Text] [Related]
19. Maternal methadone dose at delivery and neonatal abstinence syndrome.
Liu AJ; Nanan R
J Pediatr; 2010 Dec; 157(6):1044; author reply 1044-5. PubMed ID: 20888575
[No Abstract] [Full Text] [Related]
20. Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women.
Cleary BJ; Reynolds K; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ
Addiction; 2013 Apr; 108(4):762-70. PubMed ID: 23216809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
